Not applicableStudy completedNCT04601129What this trial is testingAdvantage of a Fast-recovery Protocol for Minimally Invasive Kidney SurgeryWho this might be right forRenal Cell Carcinoma University Hospital, Lille 60
Testing effectiveness (Phase 2)WithdrawnNCT00176280What this trial is testingRandomized Phase 2 Trial of Pre-chemotherapy Leukine vs. Leukine-Dexamethasone in Combination With Gemzar & 5-FU in Patients With Metastatic Renal Cell CarcinomaWho this might be right forRenal Cell Carcinoma University of Kentucky
Very early researchStudy completedNCT00405366What this trial is testingSorafenib in Treating Patients Undergoing Surgery for Stage II, Stage III, or Stage IV Kidney CancerWho this might be right forKidney Cancer UNC Lineberger Comprehensive Cancer Center 30
Testing effectiveness (Phase 2)Study completedNCT03967522What this trial is testingEvaluation of Cabozantinib in Metastatic Renal Cell Carcinoma (mRCC) With Brain MetastasesWho this might be right forMetastatic Renal Cell Carcinoma Centre Leon Berard 26
Testing effectiveness (Phase 2)Ended earlyNCT00467077What this trial is testingGefitinib and PEG-Interferon Alfa-2b in Treating Patients With Unresectable or Metastatic Kidney CancerWho this might be right forKidney Cancer California Cancer Consortium 21
Testing effectiveness (Phase 2)UnknownNCT01041482What this trial is testingA Multi-Center, Non-Controlled Clinical Study of Sorafenib Adjuvant Therapy in Advanced Renal-Cell CarcinomaWho this might be right forRenal Cell Carcinoma Chinese Academy of Medical Sciences 140
Testing effectiveness (Phase 2)Study completedNCT00039429What this trial is testingAtrasentan in Treating Patients With Locally Recurrent or Metastatic Kidney CancerWho this might be right forKidney Cancer Eastern Cooperative Oncology Group 180
Large-scale testing (Phase 3)Study completedNCT00018941What this trial is testingInterleukin-2 in Treating Patients With Metastatic Kidney CancerWho this might be right forKidney Cancer National Cancer Institute (NCI)
Post-approval studies (Phase 4)Looking for participantsNCT07405086What this trial is testingMorning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT StudyWho this might be right forAdvanced Biliary Tract CarcinomaAdvanced Head and Neck Squamous Cell CarcinomaAdvanced Hepatocellular Carcinoma+18 more OHSU Knight Cancer Institute 160
Testing effectiveness (Phase 2)Ended earlyNCT01342627What this trial is testingSorafenib in Elderly Patients With Metastatic Renal Cell CarcinomaWho this might be right forMetastatic Renal Cell Carcinoma Centro di Riferimento Oncologico - Aviano 4
Testing effectiveness (Phase 2)Looking for participantsNCT04299646What this trial is testingA Phase II Study Assessing Stereotactic Radiotherapy in Therapeutic Strategy of Oligoprogressive Renal Cell Carcinoma MetastasesWho this might be right forMetastatic Renal Cell CarcinomaRadiotherapy Centre Francois Baclesse 77
Not applicableActive Not RecruitingNCT03728842What this trial is testingSpontaneous Regression in Metastatic Melanoma and Renal Cell CarcinomaWho this might be right forMelanoma; Renal Cell Carcinoma Indiana University 19
Testing effectiveness (Phase 2)Ended earlyNCT06716853What this trial is testingA Clinical Gene Therapy Study With Hematopoietic Stem Cells for the Treatment, With Single Dose of Temferon, of Patients Suffering From Metastatic Renal Cell CarcinomaWho this might be right forClear Cell RCC Genenta Science 10
Testing effectiveness (Phase 2)Looking for participantsNCT06699602What this trial is testingCemiplimab and Fianlimab in People With Clear Cell Renal Cell CarcinomaWho this might be right forRenal Cell Carcinoma Memorial Sloan Kettering Cancer Center 10
Large-scale testing (Phase 3)Ended earlyNCT03024996What this trial is testingAtezolizumab as Adjuvant Therapy in Participants With Renal Cell Carcinoma (RCC) at High Risk of Developing Metastasis Following NephrectomyWho this might be right forRenal Cell Carcinoma Hoffmann-La Roche 778
Early research (Phase 1)Study completedNCT04504669What this trial is testingFirst Time in Human Study of AZD8701 With or Without Durvalumab in Participants With Advanced Solid TumoursWho this might be right forClear Cell Renal Cell CancerNon-Small-Cell Lung CancerTriple Negative Breast Neoplasms+6 more AstraZeneca 60
Testing effectiveness (Phase 2)Study completedNCT00459979What this trial is testingSunitinib in Treating Patients With Kidney Cancer That Cannot Be Removed by SurgeryWho this might be right forKidney Cancer Case Comprehensive Cancer Center 30
Testing effectiveness (Phase 2)WithdrawnNCT00293527What this trial is testingInterferon Alpha-2b (Intron A) for Metastatic or Unresectable Clear Cell Renal CarcinomaWho this might be right forRenal Cancer Ohio State University Comprehensive Cancer Center
Testing effectiveness (Phase 2)WithdrawnNCT02763761What this trial is testingAn Investigational Study of Infliximab With Prednisone or Methylprednisolone Versus Prednisone Combination Treatment in Immune Related or Severe Diarrhea in Patients Treated With Yervoy and/or OpdivoWho this might be right forRenal Cell CarcinomaMelanomaLung Cancer Bristol-Myers Squibb
Testing effectiveness (Phase 2)Study completedNCT00003390What this trial is testing6-Hydroxymethylacylfulvene in Treating Patients With Metastatic Kidney CancerWho this might be right forKidney Cancer Memorial Sloan Kettering Cancer Center